Four Marijuana Stocks Making Waves on Thursday

CORAL GABLES, FL / ACCESSWIRE / March 7, 2019 / When speaking about the marijuana stock market, people tend to largely focus on cannabis companies at the top of the industry, but this approach completely overlooks companies that aren't typically considered to be in the running because of their market capitalization. Typically, small-to-mid cap stock companies fare much better in volatile market conditions because, whereas larger companies are burdened by bureaucratic practices. When speaking about cannabis companies that are attracting investor attention, the focus has been on companies working with cannabidiol, given its countless applications as a form of alternative medicine. CLS Holdings USA Inc (OTC:CLSH), Cronos Group Inc (NASDAQ:CRON), Aphria Inc (APHA), and Tilray Inc (NASDAQ:TLRY) are 4 marijuana companies testing their limits on Thursday.

CLS Holdings USA Inc (OTC:CLSH) is a diversified cannabis company operating as Cannabis Life Sciences and an integrated cannabis producer and retailer in Nevada through its Oasis Cannabis subsidiaries. Like other companies in the cannabis industry, CLS is taking advantage of the recent boom in the excitement surrounding marijuana and its countless uses for improving the quality of life for consumers.

CLS Holdings USA Inc (OTC:CLSH) today announced the appointment of Samantha Schafer as Retail Operations Manager of Oasis Dispensary in Las Vegas, Per the details of the announcement, Samantha joins the team as an industry leader who has overseen cannabis management and operations for nearly a decade. With a proven track record of success, Samantha's role will focus on increasing sales through customer-focused initiatives and analyzing sales data to maximize profitable revenue generating opportunities. She specializes in Cannabis Trend Forecasting, supply chain management, and compliance, and will be a valuable asset to the team.

Following the announcement, Andrew J. Glashow, President and Chief Operating Officer of CLS Holdings USA Inc (OTC:CLSH), said, "we conducted an extensive search to fill this position and are excited to have someone with Samantha's track record of success agree to join the Oasis Cannabis team."

For More Information On CLS Holdings USA Inc, Click Here

Cronos Group Inc (CRON) found itself in headlines earlier this week when the Company announced that it had sold all of its common shares in the capital of Whistler Medical Marijuana Corporation, representing approximately 19% of Whistler's issued and outstanding common shares, to Aurora Cannabis Inc. for a total purchase price of approximately C$175 million, payable by the issuance of common shares in the capital of Aurora, and subject to certain working capital adjustments and holdbacks.

Mike Gorenstein, CEO of Cronos Group, commented, "we'd like to thank and congratulate Whistler for their partnership over the past two years. Whistler's commitment to creating high-quality products and establishing a premium brand has generated value for consumers and investors alike. We are proud to have been part of their growth and look forward to their progress through this venture."

For More Information On Cronos Group Inc, Click Here

Aphria Inc (APHA) announced on Monday that Health Canada has granted the Company its license amendment, permitting Aphria to commence production in an additional 800,000 square feet of facilities at its Aphria One location, as part of the Company's completed Part IV and Part V expansions.

Following the announcement, Irwin Simon, Interim CEO of Aphria, said, "this is a major milestone for Aphria on its path to becoming a leading global cannabis producer, as well as a positive development greatly anticipated by the Canadian cannabis industry. Aphria's progress expanding production and automation is essential to our strategy of securing scale and long-term advantages that enable the evolution of the cannabis industry through product and brand innovation."

For More Information On Aphria Inc, Click Here

Tilray Inc (TLRY), a global leader in cannabis research, cultivation, production, and distribution, yesterday announced that its wholly-owned subsidiary Tilray Portugal Unipessoal Lda. has completed a successful harvest of medical cannabis at the Company's European Union Campus in Portugal. Tilray's EU Campus in Portugal is a multi-faceted production facility that includes indoor, outdoor and greenhouse cultivation sites, as well as research labs, processing, packaging and distribution sites for medical cannabis and cannabinoid-derived medical products.